有道理，我只是在质疑它的科学基础如果论文这样，学生是毕不了业的。
所以，我在等他的科学论文。
现在市场和人民都需要心理期盼，所以他们这样做可以理解。
如果有学术常规的支持就更好。
最大的疑问是需要早期用药，而早期的病人，后期怎么发展也是不确定的，说不定根本就不需治疗，给药只是起来安慰剂的作用。 这也是为什么要双盲的理由之一，既然已经是双盲了 那么安慰剂组的表现如何呢？还没有披露。
外面也不是没有质疑的声音
https://www.statnews.com/2020/04/27/the-world-wants-answers-on-gileads-covid-19-drug-experts-worry-next-studies-may-increase-uncertainty/
The world wants answers on Gilead’s Covid-19 drug. Experts worry next studies may increase uncertainty
The main concern, they say, stems from the fact that the Gilead trial expected to read out this week, which was conducted among patients with severe disease, lacks a control group — that is, patients who are randomly assigned to receive the best treatment available, but not remdesivir. As designed, the only randomization is the duration of treatment: either five days or 10 days of drug. Without a true control group of patients, many experts say, it will be difficult to determine whether remdesivir is effective.
The world wants answers on Gilead’s Covid-19 drug. Experts worry next studies may increase uncertainty
The main concern, they say, stems from the fact that the Gilead trial expected to read out this week, which was conducted among patients with severe disease, lacks a control group — that is, patients who are randomly assigned to receive the best treatment available, but not remdesivir. As designed, the only randomization is the duration of treatment: either five days or 10 days of drug. Without a true control group of patients, many experts say, it will be difficult to determine whether remdesivir is effective.
Huasing Association 1999 - 2013